Ayonix Pharmaceutical Private Limited
About Ayonix Pharmaceutical Private Limited
Data last updated:
Ayonix Pharmaceutical Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47721MH2023PTC402801.
The company has an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Namdeo Rajaram Chavan and Chandrashekhar Pralhad Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aurangabad, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.4 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1,191 (net margin -0.2%) and EBITDA of -₹1,191 (EBITDA margin -0.2%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No E3 – 104 Gut No 138, Himalaya Residency Devlai, Aurangabad, Maharashtra, India – 431007
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ayonix Pharmaceutical Private Limited
The main business activity of Ayonix Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ayonix Pharmaceutical Private Limited FY 2025 filings available
Ayonix Pharmaceutical Private Limited reported revenue of ₹5.4 Lakh (up 548% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ayonix Pharmaceutical Private Limited
Revenue rose 548% in the latest year. EBITDA rose 100% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Ayonix Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹1,191 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹1,191 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Ayonix Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.2% | •••• |
| Net Profit Margin | -0.2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ayonix Pharmaceutical are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ayonix Pharmaceutical Private Limited
Ayonix Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Namdeo Rajaram Chavan | Director | 12 May 2023 | 3 Years 5 Months | Current |
| Chandrashekhar Pralhad Patil | Additional Director | 10 Mar 2025 | 1 Years 7 Months | Current |
Peer Comparison of Ayonix Pharmaceutical Private Limited
Ayonix Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deekim Surgicals Private Limited | ₹5.76 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Jagdishpur, Bihar, India |
| Jorak Life Science (OPC) Private Limited | ₹5.7 Lakh (FY 2025) | •••• | •••• | •••• | Nagpur, Maharashtra, India | |
| Nakoda Health Solution Private Limited | ₹5.69 Lakh (FY 2025) | •••• | •••• | •••• | Mehkar, Maharashtra, India | |
| Herbalbyte Solutions (OPC) Private Limited | ₹5.62 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Humanglow Pharma Private Limited | ₹5.44 Lakh (FY 2024) | •••• | •••• | •••• | Nalagarh, Himachal Pradesh, India | |
| Ayonix Pharmaceutical Private Limited this company | ₹5.4 Lakh (FY 2025) | •••• | •••• | 548.0% | •••• | Aurangabad, Maharashtra, India |
| Gentle Care Lifescience Private Limited | ₹5.33 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Delhi, India |
| Jivanam Pharma Private Limited | ₹5.3 Lakh (FY 2025) | •••• | •••• | 128.0% | •••• | Panchkula, Haryana, India |
| Binay and Sons Pharmaceutical Industries Private Limited | ₹5.27 Lakh (FY 2024) | •••• | •••• | •••• | Ranchi, Jharkhand, India | |
| Medocfine Pharmaceutical Private Limited | ₹5.24 Lakh (FY 2024) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Lunix Pharma India Private Limited | ₹5.15 Lakh (FY 2024) | •••• | •••• | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Ayonix Pharmaceutical by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Ayonix Pharmaceutical Private Limited
Ayonix Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ayonix Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Ayonix Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ayonix Pharmaceutical Private Limited
Ayonix Pharmaceutical Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Chandrashekhar Pralhad Patil was appointed as Additional Director on 10 Mar 2025.
Credit Ratings, Litigation & Regulatory Alerts for Ayonix Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ayonix Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ayonix Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ayonix Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ayonix Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ayonix Pharmaceutical Private Limited
Ayonix Pharmaceutical is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U47721MH2023PTC402801.
Ayonix Pharmaceutical reported revenue of ₹5.4 Lakh for FY 2025 (up 548% YoY).
Ayonix Pharmaceutical has 2 current directors:
- Namdeo Rajaram Chavan - Director
- Chandrashekhar Pralhad Patil - Additional Director
Ayonix Pharmaceutical reported a net loss of ₹1,191 (net margin -0.2%) and EBITDA of -₹1,191 (EBITDA margin -0.2%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Ayonix Pharmaceutical is U47721MH2023PTC402801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ayonix Pharmaceutical was incorporated on 12 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ayonix Pharmaceutical by revenue are Deekim Surgicals Private Limited, Jorak Life Science (OPC) Private Limited, Nakoda Health Solution Private Limited, Herbalbyte Solutions (OPC) Private Limited, Humanglow Pharma Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Chandrashekhar Pralhad Patil was appointed as Additional Director on 10 Mar 2025. Nita Gajanan Jadhao ceased to be Director on 10 Mar 2025. Namdeo Rajaram Chavan was appointed as Director on 12 May 2023. Ayonix Pharmaceutical has 4 board changes on record in total.
The registered office of Ayonix Pharmaceutical is at Flat No E3 – 104 Gut No 138, Himalaya Residency Devlai, Aurangabad, Maharashtra, India – 431007.
Ayonix Pharmaceutical has an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1 Lakh.
Ayonix Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.